CD8A and myeloid sarcoma: Conceivably, such mechanisms may both include allelic differences in antigen presentation to CD8+ T cells, which may have both pathogenic and protective roles in MS or its experimental models [37–40], or effects unrelated to antigen presentation through regulation of mRNA expression of genes in the HLA locus [41].